Incretins in the Therapy of Diabetic Kidney Disease
Diabetic kidney disease is a microvascular complication that occurs in patients with diabetes. It is strongly associated with increased risk of kidney replacement therapy and all-cause mortality. Incretins are peptide hormones derived from the gastrointestinal tract, that besides causing enhancement...
Guardado en:
Autores principales: | Agnieszka Przezak, Weronika Bielka, Andrzej Pawlik |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cff00ea746964b33a16960d1ced5ad61 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Role of incretin based therapies in the treatment of diabetic kidney disease
por: Paola Fioretto, et al.
Publicado: (2018) -
Inсretin-based therapy in patients with type 2 diabetes and chronic kidney disease
por: Minara Shamkhalovna Shamkhalova, et al.
Publicado: (2012) -
Incretin-based therapy: renal effects
por: Anton Ivanovich Korbut, et al.
Publicado: (2016) -
Type 2 diabetes mellitus and the cardiometabolic syndrome: impact of incretin-based therapies
por: Schwartz S
Publicado: (2010) -
Recent Advances in Diabetic Kidney Diseases: From Kidney Injury to Kidney Fibrosis
por: Peir-Haur Hung, et al.
Publicado: (2021)